The home of a prominent Bayer executive was targeted last week in an alleged arson in New Jersey, law enforcement sources ...

Bayer has told U.S. lawmakers it could stop selling Roundup weedkiller unless they can strengthen legal protection against ...

Germany's financial markets watchdog is looking at whether Bayer fairly disclosed plans for shareholder approval of a capital ...

Germany's financial markets watchdog has started an initial probe to examine whether Bayer fairly disclosed plans to get ...

The latest health news includes Johnson & Johnson halting testing on a depression drug, USDA eliminating food safety advisory ...

Bayer reveals phase 3 data for improved MRI contrast agent Bayer is close to filing a new MRI contrast agent that can reduce levels of gadolinium, which can have health and environmental consequences.

Two companies have received approved for a generic of the 2.5 mg tablet of anticoagulant rivaroxaban, which is used to reduce ...

In a live event, Ganesh V. Raj, MD, PhD, discussed the drug-drug interactions and outcomes by disease volumes across ARPI ...

This summary highlights key global health developments, including J&J halting studies of a depression drug due to low ...

Bayer now says it expects to make €3 billion in sales for its prostate cancer treatment Nubeqa, up from an earlier estimate of €1 billion, after reviewing new data for the drug in metastatic ...